Bone scan has now been reported on.
Head & Neck: No abnormal avid osteoblastic focus in the skull, facial bones, mandible, or in the cervical spine.
Thorax & Upper Limbs: Mild degerative pattern of uptake in the sternoclavicular and acromioclavicular joints. Physiological pattern of uptake in the clavicles and upper limb bones. A small focus of low grade uptake at the anterior aspect of the left 7th rib is non specific. Uptake in remainder of ribs is non specific.
The small focus uptake on the left 7th rib is an old # osasioned when I suffered the indignity of falling between the wharf and my yacht years ago.
Lumbar spine, Pelvis & Lower Limbs: Physiological pattern of uptake in the lumbar spine, pelvic bones, hips, and in the lower limb bones. Moderate arthritic pattern of uptake in the first MTP joints.
Summary: No evidence of oesteoblastic bony metastatic pathology. A small focal activity of the 7th anteriorly is likely related to prior bony injury.
My thoughts: My prostate cancer first surfaced in November of 2006 during my annual physical with my GP. I was 56 years of age at the time. My PSA was elevated 6.0 ng/ml and DRE indicated hardening of the entire left hemisphere of my enlarged prostate. My PCa was staged at T2B following biopsy. I was treated with 9 months of neo adjuvant ADT (Lucrin as it is known in Australia), and 70 Gy of Radiation. My PSA was uneventful for 12 years then it commenced to rise ever so slowly over subsequent years. I reached the threshold for BCR (2.25 ng/ml) in 2024. I underwent a PSMA Pet Scan in October 2014. Small low grade uptake in apical prostate. Very small volume disease not requiring any salvage local treatment. No bony mets seen. One iliac region nodal uptake (SUV 12.14) activity. Node was left internal iliac node. Radiation planned for local node for temporary PSA control however during planning CT the node (size 4mm) was unable to be identified to target. Thus RT cancelled and a second PSMA scan scheduled in 3 months. Second PSMA in Feb 2025. Interval increase in avidity ( now SUV max 16.85) and a second node ( SUV 2.73, obturator node) was identified. So in a further 3 months we now have firther progression in the known node and a new node identified. Radiotherapy was given to both nodes (30 Gy and 25 Gy). PSA following Tx at 3/12 dropped 30%. PSA doubling time was never really an issue (18 to 24 months). And so here we are now stuck in a holding pattern with no active treatment for PCa. PSA bloods will be taken this week and I will report on that when available.
So my PCa journey will enter it's 20th year this year and with an initial staging of T2b, Gleason 7 (4+3), I never really expected to be in this situation in my twilight years. Still no requirement for ADT currently is a big plus, particularly give my heart failure issues.
Edited by member 08 Jun 2026 at 04:59
| Reason: Not specified